Eprodisate slows kidney decline in amyloid A amyloidosisBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.334.7606.1245-a (Published 14 June 2007) Cite this as: BMJ 2007;334:1245
Amyloid A amyloidosis is a rare complication of chronic inflammatory diseases and chronic infections⇑. In this condition, a proteolytic fragment of serum amyloid A protein—an acute phase reactant produced in the liver—is deposited extracellularly in the tissues as insoluble fibrils. Such deposition causes progressive dysfunction of organs and, eventually, death. A new drug, eprodisate, inhibits …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial